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Structured Abstract
Objective: To evaluate the influence of the maturational stages of zygomaticomaxil-
lary sutures (ZMS) on the response to maxillary protraction.
Subjects and Methods: A total of 40 Class III patients were treated retrospectively 
with either a combination of rapid maxillary expansion and facial mask (RME/FM) or 
bone- anchored maxillary protraction (BAMP). The RME/FM group consisted of 18 
patients (mean age 8.3 years), while the BAMP group was comprised of 22 patients 
(mean age 11.8 years). The initial CBCT images (T1) of the ZMSs were classified blindly. 
3D models from CBCT images at the start and at the end of orthopaedic treatment 
were registered on the anterior cranial base, and corresponding structures were meas-
ured on colour- coded maps and semitransparent overlays. The amounts of protraction 
of the maxilla, zygoma, orbitale and maxillary first molars for both groups were ana-
lysed with two- way ANOVA with Holm- Sidak post hoc test for multiple comparisons.
Results: A significant association was found between the early maturation stages of 
the ZMSs and the amount of maxillary protraction, regardless of the protraction 
method used. Class III patients with ZMS stages A and B showed greater maxillary 
protraction than patients at stage C.
Conclusion: The maturational stages of ZMS are associated with the response maxil-
lary protraction.
K E Y W O R D S
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1  | INTRODUCTION
Rapid maxillary expansion and facial mask (RME/FM) therapy typically 
is indicated for treatment of Class III malocclusion associated with 
maxillary skeletal retrusion.1-4 The effects produced by this treatment 
protocol include more convexity of the facial profile5 due to forward 
displacement of the maxilla,4 clockwise rotation of the mandible,5 pro-
clination of the maxillary incisors6 and a counterclockwise rotation of 
the palatal plane.7
To produce greater skeletal effects, early RME/FM treatment has 
been advocated. However, different chronological ages have been 
proposed as the best timing for initiating the RME/FM protocol. While 
some authors have recommended treatment up to 8 years,8 9 years9 
and 10 years of age10,11 or before puberty,12 others did not identify 
any differences in response according to chronological age.2,13,14
Great individual variability in the amount of maxillary protraction 
has been demonstrated also in patients treated with bone- anchored 
maxillary protraction (BAMP).15 BAMP is initiated in the late mixed 
dentition or early permanent dentition. De Clerck and co- workers 
state that the placement of the miniplates typically should be delayed 
until after 10 years of age because the zygomatic plates tend to fail 
more often in younger patients.16
The amount of maxillary protraction is dependent on the matura-
tion of the circummaxillary sutures, including the transverse palatine 
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suture, the frontomaxillary sutures and the zygomaticomaxillary su-
tures (ZMSs). Kambara17 demonstrated that the ZMSs presented simi-
lar histological findings, or even greater complexity of interdigitations, 
compared to other circummaxillary sutures in young (mixed dentition 
phase) and older (permanent dentition phase) monkeys. The ZMSs are 
the longest and thickest circummaxillary sutures.18-20 They are ori-
ented along the direction of the applied force system used in maxil-
lary protraction.21 Individual assessment of the maturation of ZMSs, 
therefore, may represent an indicator of the response to orthopaedic 
maxillary protraction.
In Part 1 of this investigation,22 we presented a classification of the 
maturational stages of the ZMSs. The aim of this study was to evaluate 
the influence of the maturational stages of the ZMSs on the amount 
of maxillary protraction produced by RME/FM and BAMP protocols 
in growing patients with Class III malocclusion. The differences be-
tween the two protocols were of secondary interest because the main 
goal of this study was to evaluate an adequate sample of children who 
underwent maxillary protraction at the three earliest stages of ZMS 
maturation and for whom CBCT data were available.
2  | SUBJECTS AND METHODS
The study sample was comprised of 45 Caucasian patients with Class 
III malocclusion diagnosed by a Wits appraisal of - 1 mm or less, an 
anterior cross- bite or incisor end- to- end relationship and a Class III 
molar relationship or mesial terminal step for the deciduous second 
molars. This retrospective study was approved by the Institutional 
Review Board from the University of Michigan.
Patients were treated with either RME/FM or BAMP protocols. 
The RME/FM group consisted of 18 patients (15 females, three males) 
with a mean age of 8.3 years (range from 5.6 to 10.7 years), treated 
consecutively by one orthodontist (C.T.H.) at the Methodist University 
of São Paulo in São Bernardo do Campo, Brazil. Rapid maxillary expan-
sion was accomplished by way of a banded Hyrax expander, to which 
hooks were attached for elastics. Immediately after expansion, maxil-
lary protraction was performed with an individual facial mask23 com-
bined with extraoral elastics delivering 600 to 800 g of force per side. 
Patients were asked to wear the facial mask for 14 to 16 hours per 
day. The elastics were oriented from the expander to the facial mask 
in a downward and forward direction at an angle of 15 to 30 degrees 
relative to the occlusal plane.24
The BAMP group was comprised of 22 patients (12 females and 10 
males) with a mean age of 11.8 years (range from 9.7 to 13.6 years), 
treated consecutively by one operator (H.D.C.), in a private practice 
in Brussels, Belgium. For the BAMP protocol, four miniplates (Bollard; 
Tita- Link, Brussels, Belgium) were inserted into the infrazygomatic 
crests of the maxillary buttress and between mandibular lateral inci-
sors and canines. Extensions of these plates perforated the attached 
gingiva near the mucogingival junction. The initial force was 100g/
side, progressing to a maximum force of 250g/side. Patients were 
instructed to wear the elastics 24h/day. For patients who presented 
with an anterior cross- bite, a removable maxillary biteplate was placed 
to eliminate the occlusal interference until the overjet was corrected.16 
Patients of both groups were treated at least to a positive overjet, with 
most patients overcorrected to a Class II molar relationship.
Both samples were analysed in a previous study in 2013.24 For 
the current study, two male and two female patients were excluded 
from the RME/FM group due to poor image quality (artefacts) in the 
ZMS region that did not allow a reliable evaluation of the maturational 
stage. One male patient was replaced with a female patient, as this 
girl started her treatment later than others; therefore, the final RME/
FM sample consisted of 18 patients (15 females and three males). For 
the same reason, one female and two males were excluded from the 
original BAMP group as reported in 2013.24
Cone- beam computed tomography (CBCT) scans were obtained 
from all patients using an iCATTM Cone Beam 3- D Imaging System 
(Imaging Science International, Hatfield, PA, USA). Each subject was 
seated in an upright position with the Frankfort plane (superior aspect 
of the external auditory canal to infraorbital rim line) parallel to the floor 
during the scanning process. For all scans, the minimum field of view 
(FOV) used was 16×22 cm, and the scan time was 20- 40 seconds. CBCT 
images were taken at the onset (T1) and after approximately 10 months 
for the RME/FM group and after 12 months for the BAMP group (T2).
2.1 | Classification of the ZMSs maturation
The CBCT images of the ZMSs at T1 were analysed using Invivo5™ 
software (Anatomage, San Jose, CA, USA). Head orientation in the 
three planes of space and the selection of the slice for evaluation of 
the ZMSs maturation were performed according to the protocol de-
scribed previously in the Part I of this study.22
The maturation of the ZMSs was determined in the sagittal view, 
at the infraorbital (superior) and infrazygomatic (inferior) portions of 
the suture. Radiographic interpretation was performed in the sagittal 
cross- sectional slice that best allowed visualization of the long axis 
of the ZMS. No adjustments in contrast or brightness of these im-
ages were performed. In a darkened room, the blinded ZMS samples 
were classified by one expert examiner (F.A.), according to the visual 
analysis method described in Part I of this study. Usually, the ZMSs 
of both sides presented the same maturational stage. Thus, for stag-
ing purpose, only one maturational stage of ZMSs for each patient 
was determined. Only two patients (one per group) showed different 
maturational stages of ZMSs on the right and left sides. For these 
cases, the more matured maturational stage of ZMSs was evaluated.
2.2 | Construction of 3D- surface models
To evaluate the forward displacement of the maxilla and zygomas pro-
moted by facial mask or BAMP treatments, 3D- surface models were 
constructed from CBCT images of all patients at T1 and T2. Model 
construction, cranial base registration and visualization, and assess-
ment of treatment outcomes were performed according to protocols 
described in detail in previous studies.16,24,25
After acquisition, the CBCT scans were reformatted to an isotropic 
resolution of 0.5×0.5×0.5 mm to decrease the computational power 
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and the time required to compute the automated registration. Three- 
dimensional surface models of the anatomic region of interest were 
constructed using ITK- SNAP (open- source software; http://www.
itksnap.org). The initial and final 3D models were registered on ante-
rior cranial fossa structures (3D Slicer, open- source software, https://
www.slicer.org), specifically the endocranial surfaces of the cribriform 
plate region of the ethmoid bone and the internal surface of the fron-
tal bone, as these regions had completed their growth early.
The 3DSlicer software was used to orient and measure maxillary 
displacement of the 3D surface models in both groups.26 Landmarks 
were placed to quantify T2- T1 changes: Point A (the most anterior 
point in the convexity of maxilla in the median sagittal plane), centre 
of the clinical crown of the right maxillary permanent central incisor, 
right and left most inferior point of the lower border of the orbits, right 
and left infraorbital foramen, right and left most inferior and posterior 
point of the zygomas, right and left mesial- buccal cusp of the maxillary 
permanent first molar. For statistical purposes, right and left mean val-
ues were utilized. The T2- T1 changes in Point A, and zygoma average, 
orbitale average, and first molar average were measured in the antero- 
posterior, supero- inferior and 3D directions.
2.3 | Method error
Twenty images of the ZMSs were selected randomly from the total 
sample and reclassified by the same examiner (F.A.) a month later. A 
100% intra- examiner agreement was found.
Regarding the reliability of 3D- surface model measurements, 10 
randomly selected patients were remeasured by the same observer. 
Intraclass correlation coefficient with a confidence level of 95% was 
performed to assess the reproducibility of the measurements between 
T1 and T2. The reliability of the segmentation and superimposition 
methods has already been validated. 26-29
2.4 | Statistical analysis
Chi- square tests with Yates’ correction were used to assess between- 
group differences in gender distribution. The influence of the matura-
tion of ZMSs and the type of therapy (BAMP versus RME/FM) on 
the amount of three- dimensional displacements of the maxilla and 
upper permanent first molars (antero- posterior, supero- inferior and 
3D displacement measured at Point A, zygoma average, orbitale av-
erage and first molar average) was evaluated by two- way ANOVA 
with Holm- Sidak post hoc test for multiple comparisons (P<.05). The 
two- way ANOVA was performed on the T2- T1 changes for the three- 
dimensional variables when both normal distribution (Shapiro- Wilk 
test) and equality of variances (Levene’s test) were satisfied.
The power of the study was 0.82 (G*Power),30; it was calculated for 
two- way ANOVA for an effect size f of 0.55 for the three- dimensional 
displacement of the maxilla24 and a alpha value of 0.05. The statistical 
analyses were performed with statistical software packages (SPSS 12, 
SPSS Inc., Chicago, Illinois, USA; SigmaStat 3.5, Systat software, Point 
Richmond, CA).
3  | RESULTS
The intraclass correlation coefficients (ICC) showed very good intra- 
examiner agreement varying from 0.79 to 1.00 for all measurements. 
Evaluation of ZMS maturation in both the RME/FM and BAMP groups 
is shown in Table 1. Only three cases (one female and two males) of 
the BAMP group showed the more mature stages D and E. In the sta-
tistical analysis, we decided to exclude these three cases in order to 
have two treatment groups that were homogenous in terms of ZMS 
maturation stages. Thus, the BAMP group analysed statistically con-
sisted of 19 patients (11 females and eight males).
No significant between- group differences were found in gender 
distribution (chi- square test=1.775; P=.183).
Preliminary evaluation of the data showed that each dependent 
variable (T2- T1 changes for the antero- posterior, supero- inferior and 
3D directions of Point A, zygoma average, orbitale average and first 
molar average) was distributed normally (Kolmogorov- Smirnov test) 
for each combination of the groups for the two independent variables 
(ZMS maturation stage and type of therapy). The only exception was 
3D direction for the first molars that was not distributed normally. For 
this variable, two- way ANOVA was not performed. Homogeneity of 
variances for each combination of the groups for the two independent 
variables also was assessed (Levene’s test).
The descriptive data of the T2- T1 changes in the antero- posterior, 
supero- inferior and 3D directions for Point A, zygoma average, orbitale 
average and first molar average according to the different ZMS stages 
and type of therapy (BAMP and RME/FM) are shown in Tables 2 and 
3, respectively.
The antero- posterior displacement of Point A was influenced sig-
nificantly by both the maturational stage of ZMSs and the type of 
therapy (Table 4). The forward displacement of the maxilla was signifi-
cantly greater at ZMS maturational stage A and B compared to stage 
TABLE  1 Distribution of maturational stages of ZMS in RME/FM and BAMP groups
RME/FM Group BAMP Group
Gender Age (y) Gender Age (y)
Stages Female Male Mean SD Min Max Female Male Mean SD Min Max
A 4 1 7.5 1.3 5.7 8.5 3 2 11.5 1.8 9.7 13.6
B 9 1 8.2 1.6 5.6 10.2 6 4 11.9 1.1 10.0 13.6
C 4 1 9.6 1.4 7.7 10.7 3 4 12.0 1.0 11.0 13.6
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C (+1.3 mm and 1.4 mm, respectively). As for the type of therapy, the 
BAMP group demonstrated significantly greater forward displacement 
of the maxilla (+1.9 mm) compared to RME/FM treatment (Table 3). 
However, the interaction between ZMS maturational stages and type 
of therapy produced no significant effects on the antero- posterior dis-
placement of Point A (Table 4).
The supero- inferior displacement of Point A was influenced sig-
nificantly by the type of therapy, with the RME/FM group showing 
a significantly greater downward displacement of Point A than the 
BAMP group (1.2 mm, Table 4). The 3D displacement of Point A was 
influenced significantly by the type of therapy, with the BAMP group 
exhibiting a significantly greater 3D displacement than the RME/FM 
group (1.2 mm). As for the average antero- posterior displacement 
of the zygomas, only the type of therapy had a significant influence 
(Table 5). The BAMP group exhibited a significantly greater forward 
displacement of the zygomas than did the RME/FM group (1.0 mm). 
The 3D displacement of the zygomas was influenced significantly by 
the type of therapy, with the BAMP group presenting a significantly 
greater 3D displacement than the RME/FM group (0.9 mm). No signif-
icant influence of either type of therapy or maturational stage of ZMSs 
was assessed for the supero- inferior displacement of the zygomas.
The antero- posterior displacement of orbits at orbitale was influ-
enced significantly by the type of therapy and by the interaction be-
tween ZMS maturational stages and type of treatment (Table 6). The 
BAMP group showed a significantly greater forward displacement of 
the orbits with respect to RME/FM group (1.2 mm). Within both ZMS 
maturational stages A and B, the BAMP group exhibited significantly 
greater forward displacement of the orbits with respect to RME/FM 
group (2.0 mm and 1.0 mm, respectively). No significant difference 
could be recorded between the 2 types of treatment within ZMS mat-
urational stage C. When analysing the influence of the ZMS matura-
tional stages within the BAMP group, only patients treated at stage A 
showed a significantly greater forward displacement of the orbits than 
did patients treated at stage C (1.3 mm).
Within the RME/FM group, the ZMS maturational stages did not 
influence the amount of protraction of the orbits. The 3D displace-
ment of orbitale was influenced significantly by both the ZMS mat-
urational stage and the type of therapy. ZMS stage B demonstrated 
a significantly greater 3D displacement of orbitale than ZMS stage C 
(0.7 mm), while the BAMP group showed a significantly greater 3D 
displacement of orbitale compared to RME/FM group (0.8 mm). No 
significant influence of either type of therapy or maturational stage 
of ZMSs was assessed for the supero- inferior displacement of the 
orbits.
The antero- posterior displacement of first molars was influenced 
significantly by the type of therapy, with the BAMP group present-
ing with a significantly greater forward displacement of the first molar 
than the RME/FM group (1.3 mm - Table 7). No significant influence 
of either type of therapy or maturational stage of ZMSs was assessed 
for the supero- inferior displacement of the first molars.
4  | DISCUSSION
Previous experimental studies on monkeys17,19-21 have shown that 
the zygomaticomaxillary sutures and the pterygopalatine sutures 
TABLE  3 Descriptive statistics for the three- dimensional T2- T1 
changes according to the two treatment protocols (mm)
BAMP group (N=19)
RME/FM group 
(N=18)
Mean SD Mean SD
A point
A- P 3.1 1.2 1.3 1.2
S- I 0.6 1.6 1.7 1.0
3D 3.7 1.2 2.6 0.9
Average zygoma
A- P 2.1 1.1 1.1 0.8
S- I 1.2 1.0 1.0 1.0
3D 2.9 0.9 2.1 0.5
Average orbitale
A- P 1.6 0.9 0.6 0.6
S- I 0.3 0.9 0.5 0.9
3D 2.1 0.8 1.5 0.6
Average first molar
A- P 3.8 1.5 2.9 2.2
S- I 2.3 1.2 2.7 1.7
3D 4.7 1.4 4.9 1.7
SD, Standard deviation; A- P, antero- posterior; S- I,supero- inferior.
TABLE  2 Descriptive statistics for the three- dimensional T2- T1 
changes according to the different ZMS stages (mm)
ZMS stage A 
(N=9)
ZMS stage B 
(N=18)
ZMS stage C 
(N=10)
Mean SD Mean SD Mean SD
A point
A- P 2.7 1.6 2.5 1.6 1.3 0.8
S- I 0.9 1.7 0.9 1.4 1.8 1.1
3D 3.5 1.2 3.3 1.2 2.5 1.0
Average zygoma
A- P 2.0 1.2 1.7 1.2 1.2 0.7
S- I 1.2 0.8 1.1 0.9 1.1 1.3
3D 2.6 1.2 2.7 0.7 2.2 0.9
Average orbitale
A- P 1.4 1.1 1.1 1.0 0.8 0.6
S- I 0.4 0.6 0.2 1.1 0.6 0.8
3D 1.9 0.9 2.0 0.6 1.4 0.8
Average first molar
A- P 3.7 2.3 3.7 2.0 2.3 0.8
S- I 2.3 1.2 2.7 1.4 2.2 1.9
3D 5.2 1.2 5.3 1.5 3.8 1.3
SD, Standard deviation; A- P, antero- posterior; S- I, supero- inferior.
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presented similar histological findings, with more complexity of inter-
digitations compared to other circummaxillary sutures. The ZMSs are 
the longest and largest of all circummaxillary sutures.17,18,21 In an ear-
lier study, individual assessment of the maturation of the ZMSs was 
proposed as a possible indicator of the response to orthopaedic maxil-
lary protraction in Class III patients.22 Clinically, maxillary protraction 
has been shown to be unpredictable with respect to chronological age 
at the start of treatment.2,8,11,13,24
TABLE  4 Two- way ANOVA for the variable A point. The two factors tested were Treatment (BAMP and RME/FM) and the ZMS stages  
(A, B and C)
Point A
Antero- posterior
Source of variation DF SS MS F P
ZMS Stage 2 12.918 6.459 5.978 .006
Treatment 1 30.525 30.525 28.251 <.001
ZMS Stage x Treatment 2 3.565 1.782 1.650 .209
Residual 31 33.495 1.080
Total 36 80.808 2.245
Comparisons for factor: ZMS Stage
Comparison Diff. of means t P Critical level Significant?
Stage B vs Stage C 1.4 3.336 .002 0.017 Yes
Stage A vs Stage C 1.3 2.619 .014 0.025 Yes
Stage B vs Stage A 0.1 0.284 .778 0.050 No
Comparisons for factor: Treatment
Comparison Diff. of means t P Critical level Significant?
BAMP vs RME/FM 1.9 5.315 .000 0.050 Yes
Supero- inferior
Source of variation DF SS MS F P
ZMS Stage 2 6.207 3.103 2.140 .135
Treatment 1 11.120 11.120 7.666 .009
ZMS Stage x Treatment 2 7.198 3.599 2.481 .100
Residual 31 44.965 1.450
Total 36 72.559 2.016
Comparisons for factor: Treatment
Comparison Diff of means t P Critical level Significant?
RME/FM vs BAMP 1.2 2.769 .009 0.050 Yes
3D
Source of variation DF SS MS F P
ZMS Stage 2 6.052 3.026 3.191 .055
Treatment 1 12.607 12.607 13.293 <.001
ZMS Stage x Treatment 2 1.182 0.591 0.623 .543
Residual 31 29.401 0.948
Total 36 49.497 1.375
Comparisons for factor: Treatment
Comparison Diff. of means t P Critical level Significant?
BAMP vs RME/FM 1.2 3.646 .001 0.050 Yes
Differences of means were calculated on the least- square means (mm).
DF, Degrees of Freedom; SS, sum of squares; MS, mean squares.
     |  157ANGELIERI Et AL.
The present study showed that the stage of ZMS maturation was 
significantly associated with the amount of maxillary protraction. A sig-
nificantly greater forward displacement of the maxilla (measured at Point 
A) was found when treatment with either BAMP or RME/FM was per-
formed at ZMS maturational stages A and B compared to stage C (1.3 mm 
and 1.4 mm, respectively; Table 4). There was greater protraction of the 
orbits at orbitale in the BAMP group at ZMS maturational stage A vs 
stage C (1.3 mm) (Table 6). Stage C demonstrated many bony bridges 
along the ZMS that presumably hampered the forward displacement of 
the maxilla and the orbits in the BAMP group, reflecting less maxillary 
protraction compared to stages A and B for both groups (Figures 1-4).
The type of therapy also influenced the response to maxillary pro-
traction significantly. BAMP treatment promoted greater forward dis-
placement of Point A, the zygomas, and the orbits than did RME/FM 
treatment (1.0- 1.2 mm, Tables 4-6), corroborating the results of Hino 
et al.24 However, one of the limitation of these previous studies is that 
displacement measurements were made from iterative closest point 
(ICP). ICP does not distinguish between vertical and AP displacement 
nor does it record displacement of analogous landmarks. This study uti-
lizes the methods described by Yatabe et al.29 to measure 3D displace-
ments between analogous points and the x, y and z components of 
these 3D distances. It also incorporated standardized reference planes 
into the registered models. It is interesting to note that RME/FM ther-
apy produced significantly greater displacement of Point A in a down-
ward direction with respect to the BAMP protocol (1.2 mm; Table 4).
According to chronological age, greater skeletal results would be 
expected in RME/FM patients, because this group was younger than 
the BAMP group at the start of treatment. Usually, BAMP has been 
TABLE  5 Two- way ANOVA for the variable Zygoma Average. The two factors tested were Treatment (BAMP and RME/FM) and the ZMS 
stages (A, B and C)
Zygoma average
Antero- posterior
Source of variation DF SS MS F P
ZMS Stage 2 2.423 1.211 1.473 .245
Treatment 1 7.802 7.802 9.488 .004
ZMS Stage x Treatment 2 4.761 2.380 2.895 .070
Residual 31 25.491 0.822
Total 36 42.491 1.180
Comparisons for factor: Treatment
Comparison Diff of means t P Critical level Significant?
BAMP vs RME/FM 1.0 3.080 .004 0.050 Yes
Supero- inferior
Source of variation DF SS MS F P
ZMS Stage 2 0.126 0.063 0.073 .930
Treatment 1 1.319 1.319 1.520 .227
ZMS Stage x Treatment 2 5.945 2.973 3.425 .051
Residual 31 26.907 0.868
Total 36 33.150 0.921
3D
Source of variation DF SS MS F P
ZMS Stage 2 2.351 1.175 2.474 .101
Treatment 1 7.426 7.426 15.630 <.001
ZMS Stage x Treatment 2 2.127 1.063 2.238 .124
Residual 31 14.729 0.475
Total 36 26.428 0.734
Comparisons for factor: Treatment
Comparison Diff of means t P Critical level Significant?
BAMP vs RME/FM 0.9 3.953 .000 0.050 Yes
Differences of means were calculated on the least- square means.
DF, Degrees of Freedom; SS, sum of squares; MS, mean squares.
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recommended during the late mixed dentition or early permanent den-
tition or when the patient has reached 10 years of age31,32 because 
most of the failures of zygomatic plates occurred in the youngest 
patients.16 The anchorage of BAMP essentially is skeletal and the or-
thopaedic forces are applied close to the circummaxillary sutures, in-
creasing its orthopaedic effects.
TABLE  6 Two- way ANOVA for the variable Orbitale Average. The two factors tested were Treatment (BAMP and RME/FM) and the ZMS 
stages (A, B and C)
Orbitale average
Antero- posterior
Source of variation DF SS MS F P
ZMS Stage 2 1.534 0.767 1.636 .211
Treatment 1 10.953 10.953 23.368 <.001
ZMS Stage x Treatment 2 3.236 1.618 3.452 .044
Residual 31 14.531 0.469
Total 36 30.687 0.852
Comparisons for factor: Treatment
Comparison Diff of means t P Critical level Significant?
BAMP vs RME/FM 1.2 4.834 .000 0.050 Yes
Comparisons for factor: Treatment within ZMS Stage B
BAMP vs RME/FM 1.0 3.264 .003 0.050 Yes
Comparisons for factor: Treatment within ZMS Stage C
BAMP vs RME/FM 0.4 0.826 .415 0.050 No
Comparisons for factor: Treatment within ZMS Stage A
BAMP vs RME/FM 2.0 4.427 .000 0.050 Yes
Comparisons for factor: ZMS Stage within BAMP
Stage A vs Stage C 1.3 3.237 .003 0.017 Yes
Stage B vs Stage C 0.8 2.127 .041 0.025 No
Stage A vs Stage B 0.6 1.423 .165 0.050 No
Comparisons for factor: ZMS Stage within RME/FM
Stage B vs Stage A 0.4 1.031 .311 0.017 No
Stage C vs Stage A 0.3 0.674 .505 0.025 No
Stage B vs Stage C 0.1 0.226 .823 0.050 No
Supero- inferior
Source of variation DF SS MS F P
ZMS Stage 2 1.340 0.670 0.847 .438
Treatment 1 0.248 0.248 0.313 .580
ZMS Stage x Treatment 2 1.391 0.695 0.879 .425
Residual 31 24.537 0.792
Total 36 27.919 0.776
3D
ZMS Stage 2 3.395 1.697 3.853 .032
Treatment 1 4.671 4.671 10.603 .003
ZMS Stage x Treatment 2 1.675 0.838 1.901 .166
Residual 31 13.657 0.441
Total 36 22.710 0.631
(Continues)
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Despite the higher force delivered by RME/FM treatment, the force 
is applied to the expander attached to the maxillary teeth dissipating 
the force to the periodontal ligament area.31,33 Probably, because of 
that, the ZMS maturational stages did not influence the quantity of the 
protraction of the orbits in the RME/FM group (Table 5). In addition, it 
should be noted that the response to maxillary protraction is highly de-
pendent on patient cooperation. Patient compliance tends to be lower 
in patients with a facial mask compared to BAMP with Class III elastics.31
While the ZMS maturational stages and type of therapy may influ-
ence the amount and/or direction of maxillary protraction, the inter-
action between these factors was not statistically significant for the 
antero- posterior displacement of Point A (Table 4). This finding prob-
ably can be explained by a significantly greater maxillary protraction 
with the BAMP protocol compared to the RME/FM protocol only in 
patients at ZMS Stages A or B. No significant differences between the 
two therapies were found in the amount of maxillary protraction for 
patients with ZMS Stage C. On the other hand, there was a significant 
interaction between ZMS maturational stages and type of therapy 
in the forward displacement of the orbits. The BAMP group demon-
strated greater forward displacement of the orbits at ZMS matura-
tional stages A and B with respect to RME/FM (2.0 mm and 1.0 mm, 
respectively; Table 6).
The ZMS were evaluated on both sides and, when they presented 
different maturational stages, the more mature stage of ZMSs was 
considered. One of these cases presented ZMS stage B on the right 
side and A on the left. In this patient, probably the clinical difference in 
TABLE  7 Two- way ANOVA for the variable First Molar Average. The two factors tested were Treatment (BAMP and RME/FM) and the ZMS 
stages (A, B and C).
First molar average
Antero- posterior
Source of variation DF SS MS F P
ZMS Stage 2 13.232 6.616 2.310 .116
Treatment 1 13.552 13.552 4.732 .037
ZMS Stage x Treatment 2 14.491 7.246 2.530 .096
Residual 31 88.783 2.864
Total 36 127.494 3.541
Comparisons for factor: Treatment
Comparison Diff of means t P Critical level Significant?
BAMP vs RME/FM 1.3 2.175 .037 0.050 Yes
Supero- inferior
Source of variation DF SS MS F P
ZMS Stage 2 2.447 1.224 0.614 .548
Treatment 1 0.111 0.111 0.055 .815
ZMS Stage x Treatment 2 12.407 6.203 3.111 .059
Residual 31 61.819 1.994
Total 36 77.930 2.165
Differences of means were calculated on the least- square means (mm).
DF, Degrees of Freedom; SS, sum of squares; MS, mean squares.
Comparisons for factor: ZMS Stage
Comparison Diff of means t P Critical level Significant?
Stage B vs Stage C 0.7 2.776 .009 0.017 Yes
Stage A vs Stage C 0.5 1.532 .136 0.025 No
Stage B vs Stage A 0.3 0.970 .339 0.050 No
Comparisons for factor: Treatment
BAMP vs RME/FM 0.8 3.256 .003 0.050 Yes
Differences of means were calculated on the least- square means (mm).
DF, Degrees of Freedom; SS, sum of squares; MS, mean squares.
TABLE  6  (Continued)
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response to treatment would be insignificant as the maxillary protrac-
tion showed a very satisfactory result on both sides. Another patient 
who presented with ZMS stage B on the right side and stage C on the 
left had a very poor protraction effect of the maxilla. It is possible that 
the ZMS stage C hampered the maxillary protraction on both sides. 
For these cases, we considered the more mature maturational stage 
of ZMS for the statistical analysis. However, future investigations are 
needed to evaluate the clinical importance of a one- sided fusion or 
more advanced maturational stage of the ZMS.
The CBCT images of three patients showing ZMS maturational 
stage D (one female and one male patient, both 12.5 years of age) or 
stage E (a 13- year- old male patient) were analysed but were removed 
from the original BAMP sample for statistical reasons. It is interesting to 
note that these patients did not exhibit much maxillary protraction, with 
F IGURE  1 Patient with good response 
from rapid maxillary expansion and facial 
mask treatment and zygomaticomaxillary 
sutures at stage B. Colour- coded map 
is used for visualization of the maxillary 
protraction and graphic display of the 3D 
surface distances in mm [Colour figure can 
be viewed at wileyonlinelibrary.com]
F IGURE  2 Patient in the rapid maxillary 
expansion and facial mask group who 
presented poor response to maxillary 
protraction. Note that zygomaticomaxillary 
sutures were at Stage C. Colour- coded 
map is used for visualization purposes and 
graphic display of the 3D surface distances 
in mm [Colour figure can be viewed at 
wileyonlinelibrary.com]
F IGURE  3 Patient with 
zygomaticomaxillary sutures at Stage A 
and marked response of maxillary and 
zygomatic protraction with bone- anchored 
maxillary protraction treatment. Colour- 
coded map is used for visualization 
purposes and graphic display of the 3D 
surface distances in mm [Colour figure can 
be viewed at wileyonlinelibrary.com]
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F IGURE  4 Patient in the bone- 
anchored maxillary protraction group who 
presented poor response to maxillary 
protraction. Note that zygomaticomaxillary 
sutures were at Stage C. Colour- coded 
map is used for visualization purposes and 
graphic display of the 3D surface distances 
in mm [Colour figure can be viewed at 
wileyonlinelibrary.com]
F IGURE  5 Patient at Stage D of zygomaticomaxillary sutures maturation, who presented mostly vertical response to maxillary protraction 
with bone- anchored maxillary protraction, as can be seen in the semi- transparent overlay in the right. Colour- coded map is used for visualization 
purposes and graphic display of the 3D surface distances in mm. In semi- transparent overlay in the right, the time 1 surface model is shown in 
green and the time 2 is shown in transparent white [Colour figure can be viewed at wileyonlinelibrary.com]
F IGURE  6 Boy with zygomaticomaxillary sutures at Stage D demonstrating only little vertical effect after bone- anchored maxillary 
protraction treatment. Colour- coded map is used for visualization purposes and graphic display of the 3D surface distances in mm. In semi- 
transparent overlay in the right, the time 1 surface model is shown in red and the time 2 is shown in transparent white [Colour figure can be 
viewed at wileyonlinelibrary.com]
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both patients at stage D presenting an antero- posterior displacement 
of the maxilla of about −0.5 mm, with no sagittal effect at the zygomas 
and orbits. The main effect was in a vertical direction, with an inferior 
displacement of maxilla of 1.5 mm and 1.7 mm (Figures 5 and 6).
Interestingly, the patient at stage E showed no sagittal or verti-
cal effect in maxilla position (−1.2 mm and −0.2 mm, respectively) or 
the position of the orbits, with only inferior displacement of the zy-
gomas (1.6 mm; Figure 7) observed. In this patient, the BAMP proto-
col seemed to produce some vertical skeletal effects while presenting 
with a more mature ZMS stage. This preliminary finding needs to be 
confirmed in samples of patients with more mature ZMS stages.
This study applied a validated classification of maturation of ZMS 
to individually assess the morphology of this circummaxillary suture 
prior to orthopaedic maxillary protraction, mainly for juvenile and early 
adolescent patients for whom this treatment still is unpredictable. This 
method potentially can predict a good response from RME/FM treat-
ment for patients at stages A or B up to 15 years of age or avoid the fail-
ure and side effects of the BAMP or RME/FM treatments for younger 
patients showing fusion of ZMSs. However, the sample size for some 
maturational stages of ZMS was relatively small in the present study, 
and future investigations of stages D and E, in which the ZMSs are 
fused, may further elucidate the clinical responses at each ZMS stage.
Thus, the acquisition of a pre- treatment small field CBCT image 
including the ZMS region may be used as a triage tool for prediction 
of the orthopaedic result for BAMP and RME/FM as well to evalu-
ate bone quality and thickness in the infrazygomatic crest for BAMP 
placement, at a relatively low radiation dose. Future studies, however, 
would be recommended using a larger sample to confirm our results 
prior the application of the present classification method in the clinical 
practice.
5  | CONCLUSIONS
The early maturational stages of the ZMS are related directly to the 
greater amount of maxillary protraction response resulting from RME/
FM or BAMP treatments. Class III patients with ZMS stages A and B 
demonstrated greater maxillary protraction than patients at stage C 
(Point A and orbitale region).
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